Daily 800 mg versus 600 mg Efavirenz for HIV Patients Treating Tuberculosis with a Rifampicin-Based Regimen: An Open Label Randomized Controlled Trial

Figure 4

HIV viral load (log 10) trajectories over time during antiretroviral treatment outcome in 123 participants using EFV and RIF regimens according to trial arm (800mg EFV-regimen or 600mg EFV-regimen). Full lines are correlation-adjusted trajectories. Dotted lines are the confidence bands (CI=95%). (a) HIV viral load (log 10) trajectories over time. (b) HIV viral load trajectories over time for initial HIV viral load (log 10) ≥ 5. (c) HIV viral load trajectories over time for initial HIV viral load (log 10) < 5. (d) HIV viral load (log 10) trajectories over time in patients with >50kg (EFV600 N= 50 / EFV600 N= 48).

(a)

(b)

(c)

(d)